{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T04:07:33Z","timestamp":1775275653504,"version":"3.50.1"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T00:00:00Z","timestamp":1674000000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T00:00:00Z","timestamp":1674000000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s11010-023-04658-7","type":"journal-article","created":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T06:03:13Z","timestamp":1674021793000},"page":"2271-2279","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Receptor-dependent effects of sphingosine-1-phosphate (S1P) in COVID-19: the black side of the moon"],"prefix":"10.1007","volume":"478","author":[{"given":"Hayder M.","family":"Al-kuraishy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaber El-Saber","family":"Batiha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali I.","family":"Al-Gareeb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nasser A. Hadi","family":"Al-Harcan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nermeen N.","family":"Welson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,1,18]]},"reference":[{"issue":"11","key":"4658_CR1","doi-asserted-by":"publisher","first-page":"4161","DOI":"10.1007\/s11010-021-04232-z","volume":"476","author":"HM Al-Kuraishy","year":"2021","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Alzahrani KJ, Cruz-Martins N, Batiha GE (2021) The potential role of neopterin in Covid-19: a new perspective. Mol Cell Biochem 476(11):4161\u20134166. https:\/\/doi.org\/10.1007\/s11010-021-04232-z","journal-title":"Mol Cell Biochem"},{"issue":"6","key":"4658_CR2","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1007\/s10787-022-01080-1","volume":"30","author":"AO Babalghith","year":"2022","unstructured":"Babalghith AO, Al-Kuraishy HM, Al-Gareeb AI, De Waard M, Al-Hamash SM, Jean-Marc S, Negm WA, Batiha GE (2022) The role of berberine in Covid-19: potential adjunct therapy. Inflammopharmacology 30(6):2003\u20132016. https:\/\/doi.org\/10.1007\/s10787-022-01080-1","journal-title":"Inflammopharmacology"},{"issue":"12","key":"4658_CR3","doi-asserted-by":"publisher","first-page":"8195","DOI":"10.1007\/s11033-021-06770-7","volume":"48","author":"HM Al-Kuraishy","year":"2021","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Alzahrani KJ, Alexiou A, Batiha GE (2021) Niclosamide for Covid-19: bridging the gap. Mol Biol Rep 48(12):8195\u20138202. https:\/\/doi.org\/10.1007\/s11033-021-06770-7","journal-title":"Mol Biol Rep"},{"issue":"6","key":"4658_CR4","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1007\/s10787-022-01027-6","volume":"30","author":"HM Al-Kuraishy","year":"2022","unstructured":"Al-Kuraishy HM, Batiha GE, Faidah H, Al-Gareeb AI, Saad HM, Simal-Gandara J (2022) Pirfenidone and post-Covid-19 pulmonary fibrosis: invoked again for realistic goals. Inflammopharmacology 30(6):2017\u20132026. https:\/\/doi.org\/10.1007\/s10787-022-01027-6","journal-title":"Inflammopharmacology"},{"key":"4658_CR5","doi-asserted-by":"publisher","first-page":"1878410","DOI":"10.1155\/2020\/1878410","volume":"2020","author":"FN Iheagwam","year":"2020","unstructured":"Iheagwam FN, Rotimi SO (2020) Computer-aided analysis of multiple SARS-CoV-2 therapeutic targets: identification of potent molecules from African medicinal plants. Scientifica 2020:1878410. https:\/\/doi.org\/10.1155\/2020\/1878410","journal-title":"Scientifica"},{"issue":"10","key":"4658_CR6","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1007\/s00210-021-02147-6","volume":"394","author":"H Onohuean","year":"2021","unstructured":"Onohuean H, Al-Kuraishy HM, Al-Gareeb AI, Qusti S, Alshammari EM, Batiha GE (2021) Covid-19 and development of heart failure: mystery and truth. Naunyn Schmiedebergs Arch Pharmacol 394(10):2013\u20132021. https:\/\/doi.org\/10.1007\/s00210-021-02147-6","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"6","key":"4658_CR7","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1007\/s10787-022-01070-3","volume":"30","author":"GE Batiha","year":"2022","unstructured":"Batiha GE, Al-Gareeb AI, Elekhnawy E, Al-Kuraishy HM (2022) Potential role of lipoxin in the management of COVID-19: a narrative review. Inflammopharmacology 30(6):1993\u20132001. https:\/\/doi.org\/10.1007\/s10787-022-01070-3","journal-title":"Inflammopharmacology"},{"key":"4658_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10787-022-01087-8","volume":"23","author":"GE Batiha","year":"2022","unstructured":"Batiha GE, Al-Kuraishy HM, Al-Gareeb AI, Alruwaili M, AlRuwaili R, Albogami SM, Alorabi M, Saad HM, Simal-Gandara J (2022) Targeting of neuroinflammation by glibenclamide in Covid-19: old weapon from arsenal. Inflammopharmacology 23:1\u20137. https:\/\/doi.org\/10.1007\/s10787-022-01087-8","journal-title":"Inflammopharmacology"},{"issue":"11","key":"4658_CR9","doi-asserted-by":"publisher","first-page":"11169","DOI":"10.1007\/s11033-022-07822-2","volume":"49","author":"HM Al-Kuraishy","year":"2022","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Elekhnawy E, Batiha GE (2022) Nitazoxanide and COVID-19: a review. Mol Biol Rep 49(11):11169\u201311176. https:\/\/doi.org\/10.1007\/s11033-022-07822-2","journal-title":"Mol Biol Rep"},{"issue":"1","key":"4658_CR10","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.tcb.2011.09.003","volume":"22","author":"M Maceyka","year":"2012","unstructured":"Maceyka M, Harikumar KB, Milstien S, Spiegel S (2012) Sphingosine-1-phosphate signaling and its role in disease. Trends Cell Biol 22(1):50\u201360. https:\/\/doi.org\/10.1016\/j.tcb.2011.09.003","journal-title":"Trends Cell Biol"},{"issue":"6","key":"4658_CR11","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1161\/CIRCRESAHA.107.165845","volume":"102","author":"K Venkataraman","year":"2008","unstructured":"Venkataraman K, Lee YM, Michaud J, Thangada S, Ai Y, Bonkovsky HL, Parikh NS, Habrukowich C, Hla T (2008) Vascular endothelium as a contributor of plasma sphingosine 1-phosphate. Circ Res 102(6):669\u2013676. https:\/\/doi.org\/10.1161\/CIRCRESAHA.107.165845","journal-title":"Circ Res"},{"issue":"3","key":"4658_CR12","doi-asserted-by":"publisher","first-page":"344","DOI":"10.3390\/molecules22030344","volume":"22","author":"NJ Pyne","year":"2017","unstructured":"Pyne NJ, Pyne S (2017) Sphingosine 1-phosphate receptor 1 signaling in mammalian cells. Molecules (Basel, Switzerland) 22(3):344. https:\/\/doi.org\/10.3390\/molecules22030344","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"5","key":"4658_CR13","doi-asserted-by":"publisher","first-page":"e12836","DOI":"10.1111\/cmi.12836","volume":"20","author":"AM Bryan","year":"2018","unstructured":"Bryan AM, Del Poeta M (2018) Sphingosine-1-phosphate receptors and innate immunity. Cell Microbiol 20(5):e12836. https:\/\/doi.org\/10.1111\/cmi.12836","journal-title":"Cell Microbiol"},{"issue":"1","key":"4658_CR14","doi-asserted-by":"publisher","first-page":"R440","DOI":"10.1152\/ajpregu.00085.2006","volume":"292","author":"JN Lorenz","year":"2007","unstructured":"Lorenz JN, Arend LJ, Robitz R, Paul RJ, MacLennan AJ (2007) Vascular dysfunction in S1P2 sphingosine 1-phosphate receptor knockout mice. Am J Physiol Regul Integr Comp Physiol 292(1):R440\u2013R446. https:\/\/doi.org\/10.1152\/ajpregu.00085.2006","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"4658_CR15","doi-asserted-by":"publisher","first-page":"104793","DOI":"10.1016\/j.phrs.2020.104793","volume":"156","author":"E Jozefczuk","year":"2020","unstructured":"Jozefczuk E, Guzik TJ, Siedlinski M (2020) Significance of sphingosine-1-phosphate in cardiovascular physiology and pathology. Pharmacol Res 156:104793. https:\/\/doi.org\/10.1016\/j.phrs.2020.104793","journal-title":"Pharmacol Res"},{"issue":"7","key":"4658_CR16","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1172\/jci38575","volume":"119","author":"E Camerer","year":"2009","unstructured":"Camerer E, Regard JB, Cornelissen I, Srinivasan Y, Duong DN, Palmer D, Pham TH, Wong JS, Pappu R, Coughlin SR (2009) Sphingosine-1-phosphate in the plasma compartment regulates basal and inflammation-induced vascular leak in mice. J Clin Investig 119(7):1871\u20131879. https:\/\/doi.org\/10.1172\/jci38575","journal-title":"J Clin Investig"},{"key":"4658_CR17","doi-asserted-by":"publisher","first-page":"110156","DOI":"10.1016\/j.cellsig.2021.110156","volume":"88","author":"Y Okamoto","year":"2021","unstructured":"Okamoto Y, Kitakaze K, Takenouchi Y, Yamamoto S, Ishimaru H, Tsuboi K (2021) Sphingosine 1-phosphate receptor type 2 positively regulates interleukin (IL)-4\/IL-13-induced STAT6 phosphorylation. Cell Signal 88:110156. https:\/\/doi.org\/10.1016\/j.cellsig.2021.110156","journal-title":"Cell Signal"},{"key":"4658_CR18","doi-asserted-by":"publisher","first-page":"4806541","DOI":"10.1155\/2017\/4806541","volume":"2017","author":"NC Hait","year":"2017","unstructured":"Hait NC, Maiti A (2017) The role of sphingosine-1-phosphate and ceramide-1-phosphate in inflammation and cancer. Mediat Inflamm 2017:4806541. https:\/\/doi.org\/10.1155\/2017\/4806541","journal-title":"Mediat Inflamm"},{"issue":"2","key":"4658_CR19","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/rmv.1718","volume":"23","author":"JM Carr","year":"2013","unstructured":"Carr JM, Mahalingam S, Bonder CS, Pitson SM (2013) Sphingosine kinase 1 in viral infections. Rev Med Virol 23(2):73\u201384. https:\/\/doi.org\/10.1002\/rmv.1718","journal-title":"Rev Med Virol"},{"issue":"18","key":"4658_CR20","doi-asserted-by":"publisher","first-page":"6773","DOI":"10.3390\/ijms21186773","volume":"21","author":"E Meacci","year":"2020","unstructured":"Meacci E, Garcia-Gil M, Pierucci F (2020) SARS-CoV-2 infection: a role for S1P\/S1P receptor signaling in the nervous system? Int J Mol Sci 21(18):6773. https:\/\/doi.org\/10.3390\/ijms21186773","journal-title":"Int J Mol Sci"},{"issue":"12","key":"4658_CR21","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.3390\/v11121097","volume":"11","author":"JJ Wolf","year":"2019","unstructured":"Wolf JJ, Studstill CJ, Hahm B (2019) Emerging connections of S1P-metabolizing enzymes with host defense and immunity during virus infections. Viruses 11(12):1097. https:\/\/doi.org\/10.3390\/v11121097","journal-title":"Viruses"},{"issue":"19","key":"4658_CR22","doi-asserted-by":"publisher","first-page":"7189","DOI":"10.3390\/ijms21197189","volume":"21","author":"EM McGowan","year":"2020","unstructured":"McGowan EM, Haddadi N, Nassif NT, Lin Y (2020) Targeting the SphK-S1P-SIPR pathway as a potential therapeutic approach for COVID-19. Int J Mol Sci 21(19):7189. https:\/\/doi.org\/10.3390\/ijms21197189","journal-title":"Int J Mol Sci"},{"key":"4658_CR23","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-05879-5_6","volume-title":"Sphingosine-1-phosphate signaling in immunology and infectious diseases. Current topics in microbiology and immunology","author":"MBA Oldstone","year":"2014","unstructured":"Oldstone MBA, Rosen H (2014) Cytokine storm plays a direct role in the morbidity and mortality from influenza virus infection and is chemically treatable with a single sphingosine-1-phosphate agonist molecule. In: Oldstone M, Rosen H (eds) Sphingosine-1-phosphate signaling in immunology and infectious diseases. Current topics in microbiology and immunology, vol 378. Springer, Cham. https:\/\/doi.org\/10.1007\/978-3-319-05879-5_6"},{"key":"4658_CR24","doi-asserted-by":"publisher","first-page":"218","DOI":"10.3389\/fcell.2019.00218","volume":"7","author":"A Grafen","year":"2019","unstructured":"Grafen A, Schumacher F, Chithelen J, Kleuser B, Beyersdorf N, Schneider-Schaulies J (2019) Use of acid ceramidase and sphingosine kinase inhibitors as antiviral compounds against measles virus infection of lymphocytes in vitro. Front Cell Dev Biol 7:218. https:\/\/doi.org\/10.3389\/fcell.2019.00218","journal-title":"Front Cell Dev Biol"},{"issue":"5","key":"4658_CR25","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1111\/1440-1681.13483","volume":"48","author":"Y Pan","year":"2021","unstructured":"Pan Y, Gao F, Zhao S, Han J, Chen F (2021) Role of the SphK-S1P-S1PRs pathway in invasion of the nervous system by SARS-CoV-2 infection. Clin Exp Pharmacol Physiol 48(5):637\u2013650. https:\/\/doi.org\/10.1111\/1440-1681.13483","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"4658_CR26","doi-asserted-by":"publisher","first-page":"689854","DOI":"10.3389\/fcell.2021.689854","volume":"9","author":"K T\u00f6rnquist","year":"2021","unstructured":"T\u00f6rnquist K, Asghar MY, Srinivasan V, Korhonen L, Lindholm D (2021) Sphingolipids as modulators of SARS-CoV-2 infection. Front Cell Dev Biol 9:689854. https:\/\/doi.org\/10.3389\/fcell.2021.689854","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"4658_CR27","doi-asserted-by":"publisher","first-page":"e13424","DOI":"10.15252\/emmm.202013424","volume":"13","author":"G Marfia","year":"2021","unstructured":"Marfia G, Navone S, Guarnaccia L, Campanella R, Mondoni M, Locatelli M, Barassi A, Fontana L, Palumbo F, Garzia E, Ciniglio Appiani G, Chiumello D, Miozzo M, Centanni S, Riboni L (2021) Decreased serum level of sphingosine-1-phosphate: a novel predictor of clinical severity in COVID-19. EMBO Mol Med 13(1):e13424. https:\/\/doi.org\/10.15252\/emmm.202013424","journal-title":"EMBO Mol Med"},{"issue":"24","key":"4658_CR28","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1042\/CS20210666","volume":"135","author":"MS Winkler","year":"2021","unstructured":"Winkler MS, Claus RA, Schilder M, P\u00f6hlmann S, Coldewey SM, Grundmann J, Fricke T, Moerer O, Meissner K, Bauer M, Hofmann-Winkler H, Gr\u00e4ler MH (2021) Erythrocytes increase endogenous sphingosine 1-phosphate levels as an adaptive response to SARS-CoV-2 infection. Clin Sci (London, England\u202f: 1979) 135(24):2781\u20132791. https:\/\/doi.org\/10.1042\/CS20210666","journal-title":"Clin Sci (London, England : 1979)"},{"issue":"10\u201311","key":"4658_CR29","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s00011-022-01615-w","volume":"71","author":"SS Alkhayyat","year":"2022","unstructured":"Alkhayyat SS, Al-Kuraishy HM, Al-Gareeb AI, El-Bouseary MM, AboKamer AM, Batiha GE, Simal-Gandara J (2022) Fenofibrate for COVID-19 and related complications as an approach to improve treatment outcomes: the missed key for Holy Grail. Inflamm Res 71(10\u201311):1159\u20131167. https:\/\/doi.org\/10.1007\/s00011-022-01615-w","journal-title":"Inflamm Res"},{"issue":"9","key":"4658_CR30","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1007\/s00277-022-04907-7","volume":"101","author":"HM Al-Kuraishy","year":"2022","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Kaushik A, Kujawska M, Batiha GE (2022) Hemolytic anemia in COVID-19. Ann Hematol 101(9):1887\u20131895. https:\/\/doi.org\/10.1007\/s00277-022-04907-7","journal-title":"Ann Hematol"},{"key":"4658_CR31","doi-asserted-by":"publisher","first-page":"394632022110315","DOI":"10.1177\/03946320221103151","volume":"36","author":"HM Al-Kuraishy","year":"2022","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Onohuean H, El-Saber Batiha G (2022) COVID-19 and erythrocrine function: the roller coaster and danger. Int J Immunopathol Pharmacol 36:3946320221103151. https:\/\/doi.org\/10.1177\/03946320221103151","journal-title":"Int J Immunopathol Pharmacol"},{"key":"4658_CR32","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.3389\/fimmu.2020.01102","volume":"11","author":"F Naz","year":"2020","unstructured":"Naz F, Arish M (2020) Battling COVID-19 pandemic: sphingosine-1-phosphate analogs as an adjunctive therapy? Front Immunol 11:1102. https:\/\/doi.org\/10.3389\/fimmu.2020.01102","journal-title":"Front Immunol"},{"issue":"3","key":"4658_CR33","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.3390\/ijms22031280","volume":"22","author":"C Bernacchioni","year":"2021","unstructured":"Bernacchioni C, Ghini V, Squecco R, Idrizaj E, Garella R, Puliti E, Cencetti F, Bruni P, Donati C (2021) Role of sphingosine 1-phosphate signalling axis in muscle atrophy induced by TNF\u03b1 in C2C12 myotubes. Int J Mol Sci 22(3):1280. https:\/\/doi.org\/10.3390\/ijms22031280","journal-title":"Int J Mol Sci"},{"key":"4658_CR34","doi-asserted-by":"publisher","first-page":"108516","DOI":"10.1016\/j.intimp.2021.108516","volume":"104","author":"HM Al-Kuraishy","year":"2022","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Al-Hussaniy HA, Al-Harcan NAH, Alexiou A, Batiha GE (2022) Neutrophil extracellular traps (NETs) and Covid-19: a new frontiers for therapeutic modality. Int Immunopharmacol 104:108516. https:\/\/doi.org\/10.1016\/j.intimp.2021.108516","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"4658_CR35","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s10787-022-00988-y","volume":"30","author":"HM Al-Kuraishy","year":"2022","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Alkazmi L, Habotta OA, Batiha GE (2022) High-mobility group box 1 (HMGB1) in COVID-19: extrapolation of dangerous liaisons. Inflammopharmacology 30(3):811\u2013820. https:\/\/doi.org\/10.1007\/s10787-022-00988-y","journal-title":"Inflammopharmacology"},{"key":"4658_CR36","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.3389\/fimmu.2020.01149","volume":"11","author":"L Hou","year":"2020","unstructured":"Hou L, Yang L, Chang N, Zhao X, Zhou X, Dong C, Liu F, Yang L, Li L (2020) Macrophage sphingosine 1-phosphate receptor 2 blockade attenuates liver inflammation and fibrogenesis triggered by NLRP3 inflammasome. Front Immunol 11:1149. https:\/\/doi.org\/10.3389\/fimmu.2020.01149","journal-title":"Front Immunol"},{"key":"4658_CR37","doi-asserted-by":"publisher","first-page":"642822","DOI":"10.3389\/fphar.2021.642822","volume":"12","author":"HM Al-Kuraishy","year":"2021","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Alqarni M, Cruz-Martins N, El-Saber Batiha G (2021) Pleiotropic effects of tetracyclines in the management of Covid-19: emerging perspectives. Front Pharmacol 12:642822. https:\/\/doi.org\/10.3389\/fphar.2021.642822","journal-title":"Front Pharmacol"},{"key":"4658_CR38","doi-asserted-by":"publisher","DOI":"10.1080\/02648725.2022.2122291","author":"HM Al-Kuraishy","year":"2022","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Al-Maiahy TJ, Alexiou A, Mukerjee N, Batiha GE (2022) An insight into the placental growth factor (PlGf)\/angii axis in Covid-19: a detrimental intersection. Biotechnol Genet Eng Rev. https:\/\/doi.org\/10.1080\/02648725.2022.2122291","journal-title":"Biotechnol Genet Eng Rev"},{"key":"4658_CR39","doi-asserted-by":"publisher","DOI":"10.1080\/02648725.2022.2122290","author":"HM Al-Kuraishy","year":"2022","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Al-Maiahy TJ, Alexiou A, Mukerjee N, Batiha GE (2022) Prostaglandins and non-steroidal anti-inflammatory drugs in Covid-19. Biotechnol Genet Eng Rev. https:\/\/doi.org\/10.1080\/02648725.2022.2122290","journal-title":"Biotechnol Genet Eng Rev"},{"issue":"11","key":"4658_CR40","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1177\/1933719119828112","volume":"26","author":"O Yoshino","year":"2019","unstructured":"Yoshino O, Yamada-Nomoto K, Kano K, Ono Y, Kobayashi M, Ito M, Yoneda S, Nakashima A, Shima T, Onda T, Osuga Y, Aoki J, Saito S (2019) Sphingosine 1 phosphate (S1P) increased IL-6 expression and cell growth in endometriotic cells. Reprod Sci (Thousand Oaks, Calif.) 26(11):1460\u20131467. https:\/\/doi.org\/10.1177\/1933719119828112","journal-title":"Reprod Sci (Thousand Oaks, Calif.)"},{"key":"4658_CR41","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-022-02346-9","author":"EH Nadwa","year":"2022","unstructured":"Nadwa EH, Al-Kuraishy HM, Al-Gareeb AI, Elekhnawy E, Albogami SM, Alorabi M, Batiha GE, De Waard M (2022) Cholinergic dysfunction in COVID-19: frantic search and hoping for the best. Naunyn-Schmiedeberg\u2019s Arch Pharmacol. https:\/\/doi.org\/10.1007\/s00210-022-02346-9","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"issue":"3","key":"4658_CR42","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1002\/jcp.24795","volume":"230","author":"CK Hsu","year":"2015","unstructured":"Hsu CK, Lee IT, Lin CC, Hsiao LD, Yang CM (2015) Sphingosine-1-phosphate mediates COX-2 expression and PGE2 \/IL-6 secretion via c-Src-dependent AP-1 activation. J Cell Physiol 230(3):702\u2013715. https:\/\/doi.org\/10.1002\/jcp.24795","journal-title":"J Cell Physiol"},{"issue":"1","key":"4658_CR43","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1165\/rcmb.2012-0411TR","volume":"49","author":"V Natarajan","year":"2013","unstructured":"Natarajan V, Dudek SM, Jacobson JR, Moreno-Vinasco L, Huang LS, Abassi T, Mathew B, Zhao Y, Wang L, Bittman R, Weichselbaum R, Berdyshev E, Garcia JG (2013) Sphingosine-1-phosphate, FTY720, and sphingosine-1-phosphate receptors in the pathobiology of acute lung injury. Am J Respir Cell Mol Biol 49(1):6\u201317. https:\/\/doi.org\/10.1165\/rcmb.2012-0411TR","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"2","key":"4658_CR44","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s10753-017-0719-x","volume":"41","author":"B Zhu","year":"2018","unstructured":"Zhu B, Luo GH, Feng YH, Yu MM, Zhang J, Wei J, Yang C, Xu N, Zhang XY (2018) Apolipoprotein M protects against lipopolysaccharide-induced acute lung injury via sphingosine-1-phosphate signaling. Inflammation 41(2):643\u2013653. https:\/\/doi.org\/10.1007\/s10753-017-0719-x","journal-title":"Inflammation"},{"issue":"4","key":"4658_CR45","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1161\/ATVBAHA.112.300484","volume":"33","author":"CK Nicholson","year":"2013","unstructured":"Nicholson CK, Lambert JP, Molkentin JD, Sadoshima J, Calvert JW (2013) Thioredoxin 1 is essential for sodium sulfide-mediated cardioprotection in the setting of heart failure. Arterioscler Thromb Vasc Biol 33(4):744\u2013751. https:\/\/doi.org\/10.1161\/ATVBAHA.112.300484","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"4658_CR46","doi-asserted-by":"publisher","first-page":"644295","DOI":"10.3389\/fmed.2021.644295","volume":"8","author":"HM Al-Kuraishy","year":"2021","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Alblihed M, Cruz-Martins N, Batiha GE (2021) COVID-19 and risk of acute ischemic stroke and acute lung injury in patients with Type II diabetes mellitus: the anti-inflammatory role of metformin. Front Med 8:644295. https:\/\/doi.org\/10.3389\/fmed.2021.644295","journal-title":"Front Med"},{"issue":"6","key":"4658_CR47","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1161\/ATVBAHA.109.185280","volume":"29","author":"MD Michaud","year":"2009","unstructured":"Michaud MD, Robitaille GA, Gratton JP, Richard DE (2009) Sphingosine-1-phosphate: a novel nonhypoxic activator of hypoxia-inducible factor-1 in vascular cells. Arterioscler Thromb Vasc Biol 29(6):902\u2013908. https:\/\/doi.org\/10.1161\/ATVBAHA.109.185280","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"4658_CR48","doi-asserted-by":"publisher","first-page":"109857","DOI":"10.1016\/j.mehy.2020.109857","volume":"143","author":"B Afsar","year":"2020","unstructured":"Afsar B, Kanbay M, Afsar RE (2020) Hypoxia inducible factor-1 protects against COVID-19: a hypothesis. Med Hypotheses 143:109857. https:\/\/doi.org\/10.1016\/j.mehy.2020.109857","journal-title":"Med Hypotheses"},{"key":"4658_CR49","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s43042-022-00354-1","volume":"23","author":"HM Al-kuraishy","year":"2022","unstructured":"Al-kuraishy HM, Al-Gareeb AI, Elekhnawy E, Batiha GE (2022) Dipyridamole and adenosinergic pathway in Covid-19: a juice or holy grail. Egypt J Med Hum Genet 23:140. https:\/\/doi.org\/10.1186\/s43042-022-00354-1","journal-title":"Egypt J Med Hum Genet"},{"issue":"7","key":"4658_CR50","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1084\/jem.20131666","volume":"211","author":"S Moriyama","year":"2014","unstructured":"Moriyama S, Takahashi N, Green JA, Hori S, Kubo M, Cyster JG, Okada T (2014) Sphingosine-1-phosphate receptor 2 is critical for follicular helper T cell retention in germinal centers. J Exp Med 211(7):1297\u20131305. https:\/\/doi.org\/10.1084\/jem.20131666","journal-title":"J Exp Med"},{"issue":"2","key":"4658_CR51","doi-asserted-by":"publisher","first-page":"e12967","DOI":"10.1111\/sji.12967","volume":"93","author":"A Jafarzadeh","year":"2021","unstructured":"Jafarzadeh A, Jafarzadeh S, Nozari P, Mokhtari P, Nemati M (2021) Lymphopenia an important immunological abnormality in patients with COVID-19: possible mechanisms. Scand J Immunol 93(2):e12967. https:\/\/doi.org\/10.1111\/sji.12967","journal-title":"Scand J Immunol"},{"issue":"12","key":"4658_CR52","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1007\/s40265-014-0264-y","volume":"74","author":"M Sanford","year":"2014","unstructured":"Sanford M (2014) Fingolimod: a review of its use in relapsing-remitting multiple sclerosis. Drugs 74(12):1411\u20131433. https:\/\/doi.org\/10.1007\/s40265-014-0264-y","journal-title":"Drugs"},{"issue":"5548","key":"4658_CR53","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1126\/science.1065323","volume":"294","author":"T Hla","year":"2001","unstructured":"Hla T, Lee MJ, Ancellin N, Paik JH, Kluk MJ (2001) Lysophospholipids\u2013receptor revelations. Science (New York, N.Y.) 294(5548):1875\u20131878. https:\/\/doi.org\/10.1126\/science.1065323","journal-title":"Science (New York, N.Y.)"},{"issue":"2","key":"4658_CR54","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1124\/jpet.116.233205","volume":"358","author":"A Cantalupo","year":"2016","unstructured":"Cantalupo A, Di Lorenzo A (2016) S1P signaling and de novo biosynthesis in blood pressure homeostasis. J Pharmacol Exp Ther 358(2):359\u2013370. https:\/\/doi.org\/10.1124\/jpet.116.233205","journal-title":"J Pharmacol Exp Ther"},{"key":"4658_CR55","doi-asserted-by":"publisher","first-page":"540","DOI":"10.3389\/fnins.2017.00540","volume":"11","author":"K Li","year":"2017","unstructured":"Li K, Konofalska U, Akg\u00fcn K, Reimann M, R\u00fcdiger H, Haase R, Ziemssen T (2017) Modulation of cardiac autonomic function by fingolimod initiation and predictors for fingolimod induced bradycardia in patients with multiple sclerosis. Front Neurosci 11:540. https:\/\/doi.org\/10.3389\/fnins.2017.00540","journal-title":"Front Neurosci"},{"issue":"3","key":"4658_CR56","doi-asserted-by":"publisher","first-page":"399","DOI":"10.4103\/2045-8932.87309","volume":"1","author":"H Ota","year":"2011","unstructured":"Ota H, Beutz MA, Ito M, Abe K, Oka M, McMurtry IF (2011) S1P(4) receptor mediates S1P-induced vasoconstriction in normotensive and hypertensive rat lungs. Pulm Circul 1(3):399\u2013404. https:\/\/doi.org\/10.4103\/2045-8932.87309","journal-title":"Pulm Circul"},{"issue":"1","key":"4658_CR57","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1002\/ehf2.13023","volume":"8","author":"WX Feng","year":"2021","unstructured":"Feng WX, Yang Y, Wen J, Liu YX, Liu L, Feng C (2021) Implication of inhaled nitric oxide for the treatment of critically ill COVID-19 patients with pulmonary hypertension. ESC Heart Fail 8(1):714\u2013718. https:\/\/doi.org\/10.1002\/ehf2.13023","journal-title":"ESC Heart Fail"},{"issue":"2","key":"4658_CR58","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1161\/HYPERTENSIONAHA.121.18363","volume":"79","author":"J Liao","year":"2022","unstructured":"Liao J, Zheng Y, Hu M, Xu P, Lin L, Liu X, Wu Y, Huang B, Ye X, Li S, Duan R, Fu H, Huang J, Wen L, Fu Y, Kilby MD, Kenny LC, Baker PN, Qi H, Tong C (2022) Impaired sphingosine-1-phosphate synthesis induces preeclampsia by deactivating trophoblastic YAP (yes-associated protein) through S1PR2 (sphingosine-1-phosphate receptor-2)-induced actin polymerizations. Hypertension (Dallas, Tex.: 1979) 79(2):399\u2013412. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.121.18363","journal-title":"Hypertension (Dallas, Tex.: 1979)"},{"issue":"5","key":"4658_CR59","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/s41577-021-00536-9","volume":"21","author":"A Bonaventura","year":"2021","unstructured":"Bonaventura A, Vecchi\u00e9 A, Dagna L, Martinod K, Dixon DL, Van Tassell BW, Dentali F, Montecucco F, Massberg S, Levi M, Abbate A (2021) Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19. Nat Rev Immunol 21(5):319\u2013329. https:\/\/doi.org\/10.1038\/s41577-021-00536-9","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"4658_CR60","doi-asserted-by":"publisher","first-page":"310","DOI":"10.2174\/1389203723666220610124303","volume":"23","author":"HM Al-Kuraishy","year":"2022","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Al-Niemi MS, Alexiou A, Batiha GE (2022) Calprotectin: the link between acute lung injury and gastrointestinal injury in covid-19: ban or boon. Curr Protein Pept Sci 23(5):310\u2013320. https:\/\/doi.org\/10.2174\/1389203723666220610124303","journal-title":"Curr Protein Pept Sci"},{"issue":"1","key":"4658_CR61","doi-asserted-by":"publisher","first-page":"15308","DOI":"10.1038\/s41598-021-94052-4","volume":"11","author":"H Liu","year":"2021","unstructured":"Liu H, Jackson ML, Goudswaard LJ, Moore SF, Hutchinson JL, Hers I (2021) Sphingosine-1-phosphate modulates PAR1-mediated human platelet activation in a concentration-dependent biphasic manner. Sci Rep 11(1):15308. https:\/\/doi.org\/10.1038\/s41598-021-94052-4","journal-title":"Sci Rep"},{"key":"4658_CR62","doi-asserted-by":"publisher","first-page":"7796","DOI":"10.1038\/ncomms8796","volume":"6","author":"S Vettorazzi","year":"2015","unstructured":"Vettorazzi S, Bode C, Dejager L, Frappart L, Shelest E, Kla\u00dfen C, Tasdogan A, Reichardt HM, Libert C, Schneider M, Weih F, Henriette Uhlenhaut N, David JP, Gr\u00e4ler M, Kleiman A, Tuckermann JP (2015) Glucocorticoids limit acute lung inflammation in concert with inflammatory stimuli by induction of SphK1. Nat Commun 6:7796. https:\/\/doi.org\/10.1038\/ncomms8796","journal-title":"Nat Commun"},{"key":"4658_CR63","doi-asserted-by":"publisher","first-page":"106504","DOI":"10.1016\/j.prostaglandins.2020.106504","volume":"152","author":"H Prakash","year":"2021","unstructured":"Prakash H, Upadhyay D, Bandapalli OR, Jain A, Kleuser B (2021) Host sphingolipids: perspective immune adjuvant for controlling SARS-CoV-2 infection for managing COVID-19 disease. Prostaglandins Other Lipid Mediat 152:106504. https:\/\/doi.org\/10.1016\/j.prostaglandins.2020.106504","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"4","key":"4658_CR64","doi-asserted-by":"publisher","first-page":"141","DOI":"10.4103\/JMAU.JMAU_63_20","volume":"8","author":"HM Al-Kuraishy","year":"2020","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Al-Niemi MS, Al-Buhadily AK, Al-Harchan NA, Lugnier C (2020) COVID-19 and phosphodiesterase enzyme type 5 inhibitors. J Microsc Ultrastruct 8(4):141\u2013145. https:\/\/doi.org\/10.4103\/JMAU.JMAU_63_20","journal-title":"J Microsc Ultrastruct"},{"issue":"13","key":"4658_CR65","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.2174\/1389450123666220810102406","volume":"23","author":"HM Al-Kuraishy","year":"2022","unstructured":"Al-Kuraishy HM, Al-Gareeb AI, Alexiou A, Batiha GE (2022) Central effects of ivermectin in alleviation of Covid-19-induced Dysauto-nomia. Curr Drug Targets 23(13):1277\u20131287. https:\/\/doi.org\/10.2174\/1389450123666220810102406","journal-title":"Curr Drug Targets"},{"issue":"8","key":"4658_CR66","doi-asserted-by":"publisher","first-page":"e0182329","DOI":"10.1371\/journal.pone.0182329","volume":"12","author":"SI Ohkura","year":"2017","unstructured":"Ohkura SI, Usui S, Takashima SI, Takuwa N, Yoshioka K, Okamoto Y, Inagaki Y, Sugimoto N, Kitano T, Takamura M, Wada T, Kaneko S, Takuwa Y (2017) Augmented sphingosine 1 phosphate receptor-1 signaling in cardiac fibroblasts induces cardiac hypertrophy and fibrosis through angiotensin II and interleukin-6. PLoS ONE 12(8):e0182329. https:\/\/doi.org\/10.1371\/journal.pone.0182329","journal-title":"PLoS ONE"},{"issue":"2","key":"4658_CR67","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1093\/cvr\/cvw256","volume":"113","author":"A Meissner","year":"2017","unstructured":"Meissner A, Miro F, Jim\u00e9nez-Altay\u00f3 F, Jurado A, Vila E, Planas AM (2017) Sphingosine-1-phosphate signalling-a key player in the pathogenesis of Angiotensin II-induced hypertension. Cardiovasc Res 113(2):123\u2013133. https:\/\/doi.org\/10.1093\/cvr\/cvw256","journal-title":"Cardiovasc Res"},{"issue":"12","key":"4658_CR68","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1007\/s00210-022-02284-6","volume":"395","author":"HM Al-Kuraishy","year":"2022","unstructured":"Al-Kuraishy HM, Al-Buhadily AK, Al-Gareeb AI, Alorabi M, Hadi Al-Harcan NA, El-Bouseary MM, Batiha GE (2022) Citicoline and COVID-19: vis-\u00e0-vis conjectured. Naunyn Schmiedebergs Arch Pharmacol 395(12):1463\u20131475. https:\/\/doi.org\/10.1007\/s00210-022-02284-6","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"5566","key":"4658_CR69","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1126\/science.1070238","volume":"296","author":"S Mandala","year":"2002","unstructured":"Mandala S, Hajdu R, Bergstrom J, Quackenbush E, Xie J, Milligan J, Thornton R, Shei GJ, Card D, Keohane C, Rosenbach M, Hale J, Lynch CL, Rupprecht K, Parsons W, Rosen H (2002) Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science (New York, N.Y.) 296(5566):346\u2013349. https:\/\/doi.org\/10.1126\/science.1070238","journal-title":"Science (New York, N.Y.)"},{"issue":"12","key":"4658_CR70","doi-asserted-by":"publisher","first-page":"9082","DOI":"10.1074\/jbc.M610318200","volume":"282","author":"ML Oo","year":"2007","unstructured":"Oo ML, Thangada S, Wu MT, Liu CH, Macdonald TL, Lynch KR, Lin CY, Hla T (2007) Immunosuppressive and anti-angiogenic sphingosine 1-phosphate receptor-1 agonists induce ubiquitinylation and proteasomal degradation of the receptor. J Biol Chem 282(12):9082\u20139089. https:\/\/doi.org\/10.1074\/jbc.M610318200","journal-title":"J Biol Chem"},{"issue":"1","key":"4658_CR71","doi-asserted-by":"publisher","first-page":"5272","DOI":"10.1038\/s41598-019-41760-7","volume":"9","author":"J Zhao","year":"2019","unstructured":"Zhao J, Zhu M, Jiang H, Shen S, Su X, Shi Y (2019) Combination of sphingosine-1-phosphate receptor 1 (S1PR1) agonist and antiviral drug: a potential therapy against pathogenic influenza virus. Sci Rep 9(1):5272. https:\/\/doi.org\/10.1038\/s41598-019-41760-7","journal-title":"Sci Rep"},{"issue":"2","key":"4658_CR72","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1124\/jpet.110.176487","volume":"337","author":"L Piali","year":"2011","unstructured":"Piali L, Froidevaux S, Hess P, Nayler O, Bolli MH, Schlosser E, Kohl C, Steiner B, Clozel M (2011) The selective sphingosine 1-phosphate receptor 1 agonist ponesimod protects against lymphocyte-mediated tissue inflammation. J Pharmacol Exp Ther 337(2):547\u2013556. https:\/\/doi.org\/10.1124\/jpet.110.176487","journal-title":"J Pharmacol Exp Ther"},{"issue":"11","key":"4658_CR73","doi-asserted-by":"publisher","first-page":"1879","DOI":"10.1002\/art.40558","volume":"70","author":"N Burg","year":"2018","unstructured":"Burg N, Swendeman S, Worgall S, Hla T, Salmon JE (2018) Sphingosine 1-phosphate receptor 1 signaling maintains endothelial cell barrier function and protects against immune\u00a0complex-induced vascular injury. Arthr Rheumatol (Hoboken, N.J.) 70(11):1879\u20131889. https:\/\/doi.org\/10.1002\/art.40558","journal-title":"Arthr Rheumatol (Hoboken, N.J.)"},{"issue":"1","key":"4658_CR74","doi-asserted-by":"publisher","first-page":"e03","DOI":"10.34172\/ipp.2021.03","volume":"7","author":"SZ Vahed","year":"2021","unstructured":"Vahed SZ, Ghiyasvand S, Khatibi SMH, Patel B, Shoja MM, Tolouian R et al (2021) Sphingosine 1 phosphate agonists (SPI); a potential agent to prevent acute lung injury in COVID-19. Immunopathol Persa 7(1):e03. https:\/\/doi.org\/10.34172\/ipp.2021.03","journal-title":"Immunopathol Persa"},{"issue":"3","key":"4658_CR75","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/s0006-291x(02)02671-2","volume":"299","author":"M Osada","year":"2002","unstructured":"Osada M, Yatomi Y, Ohmori T, Ikeda H, Ozaki Y (2002) Enhancement of sphingosine 1-phosphate-induced migration of vascular endothelial cells and smooth muscle cells by an EDG-5 antagonist. Biochem Biophys Res Commun 299(3):483\u2013487. https:\/\/doi.org\/10.1016\/s0006-291x(02)02671-2","journal-title":"Biochem Biophys Res Commun"},{"key":"4658_CR76","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3389\/fphar.2016.00167","volume":"7","author":"KV Blankenbach","year":"2016","unstructured":"Blankenbach KV, Schwalm S, Pfeilschifter J, Heringdorf DMZ (2016) Sphingosine-1-phosphate receptor-2 antagonists: therapeutic potential and potential risks. Front Pharmacol 7:167. https:\/\/doi.org\/10.3389\/fphar.2016.00167","journal-title":"Front Pharmacol"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-023-04658-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11010-023-04658-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-023-04658-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T06:07:01Z","timestamp":1695622021000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11010-023-04658-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,18]]},"references-count":76,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["4658"],"URL":"https:\/\/doi.org\/10.1007\/s11010-023-04658-7","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,18]]},"assertion":[{"value":"19 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}